Table of Content

1 Radiopharmaceuticals in Nuclear Medicine Market Overview
1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine
1.2 Radiopharmaceuticals in Nuclear Medicine Segment by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Value Comparison by Type (2024-2034)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Radiopharmaceuticals in Nuclear Medicine Segment by Application
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Value by Application: (2024-2034)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Global Radiopharmaceuticals in Nuclear Medicine Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue 2018-2029
1.4.2 Global Radiopharmaceuticals in Nuclear Medicine Sales 2018-2029
1.4.3 Global Radiopharmaceuticals in Nuclear Medicine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Radiopharmaceuticals in Nuclear Medicine Market Competition by Manufacturers
2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturers (2018-2024)
2.4 Global Radiopharmaceuticals in Nuclear Medicine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Product Type & Application
2.7 Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends
2.7.1 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Radiopharmaceuticals in Nuclear Medicine Players Market Share by Revenue
2.7.3 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Radiopharmaceuticals in Nuclear Medicine Retrospective Market Scenario by Region
3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Radiopharmaceuticals in Nuclear Medicine Global Radiopharmaceuticals in Nuclear Medicine Sales by Region: 2018-2029
3.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region: 2018-2024
3.2.2 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region: 2024-2029
3.3 Global Radiopharmaceuticals in Nuclear Medicine Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2018-2029
3.3.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2018-2024
3.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2024-2029
3.4 North America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Country
3.4.1 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2029)
3.4.3 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Country
3.5.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2029)
3.5.3 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2029)
3.6.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Country
3.7.1 Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2029)
3.7.3 Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2029)
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2024)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2024-2029)
4.1.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2018-2029)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2029)
4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2024)
4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2024-2029)
4.2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2018-2029)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2029)
5.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2024)
5.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2024-2029)
5.1.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2018-2029)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2029)
5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2024)
5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2024-2029)
5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2018-2029)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bracco Imaging S.P.A.
6.1.1 Bracco Imaging S.P.A. Corporation Information
6.1.2 Bracco Imaging S.P.A. Description and Business Overview
6.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.1.5 Bracco Imaging S.P.A. Recent Developments/Updates
6.2 Cambridge Isotope Laboratories, Inc.
6.2.1 Cambridge Isotope Laboratories, Inc. Corporation Information
6.2.2 Cambridge Isotope Laboratories, Inc. Description and Business Overview
6.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.2.5 Cambridge Isotope Laboratories, Inc. Recent Developments/Updates
6.3 Cardinal Health, Inc.
6.3.1 Cardinal Health, Inc. Corporation Information
6.3.2 Cardinal Health, Inc. Description and Business Overview
6.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.3.5 Cardinal Health, Inc. Recent Developments/Updates
6.4 Covidien, Plc
6.4.1 Covidien, Plc Corporation Information
6.4.2 Covidien, Plc Description and Business Overview
6.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.4.5 Covidien, Plc Recent Developments/Updates
6.5 Eczacibasi-Monrol
6.5.1 Eczacibasi-Monrol Corporation Information
6.5.2 Eczacibasi-Monrol Description and Business Overview
6.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.5.5 Eczacibasi-Monrol Recent Developments/Updates
6.6 Fujifilm Holdings Corporation
6.6.1 Fujifilm Holdings Corporation Corporation Information
6.6.2 Fujifilm Holdings Corporation Description and Business Overview
6.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.6.5 Fujifilm Holdings Corporation Recent Developments/Updates
6.7 GE Healthcare (Subsidiary Of General Electric Company)
6.6.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
6.6.2 GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
6.6.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Developments/Updates
6.8 IBA Group
6.8.1 IBA Group Corporation Information
6.8.2 IBA Group Description and Business Overview
6.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.8.5 IBA Group Recent Developments/Updates
6.9 Isotec, Inc. (Sigma-Aldrich)
6.9.1 Isotec, Inc. (Sigma-Aldrich) Corporation Information
6.9.2 Isotec, Inc. (Sigma-Aldrich) Description and Business Overview
6.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Developments/Updates
6.10 Lantheus Medical Imaging, Inc.
6.10.1 Lantheus Medical Imaging, Inc. Corporation Information
6.10.2 Lantheus Medical Imaging, Inc. Description and Business Overview
6.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.10.5 Lantheus Medical Imaging, Inc. Recent Developments/Updates
6.11 Nordion, Inc.
6.11.1 Nordion, Inc. Corporation Information
6.11.2 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.11.5 Nordion, Inc. Recent Developments/Updates
6.12 Ntp Radioisotopes (Pty), Ltd.
6.12.1 Ntp Radioisotopes (Pty), Ltd. Corporation Information
6.12.2 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Developments/Updates
6.13 Siemens Healthcare (Subsidiary Of Siemens AG)
6.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
6.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments/Updates
6.14 Taiyo Nippon Sanso Corporation
6.14.1 Taiyo Nippon Sanso Corporation Corporation Information
6.14.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.14.5 Taiyo Nippon Sanso Corporation Recent Developments/Updates
6.15 Urenco Limited
6.15.1 Urenco Limited Corporation Information
6.15.2 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.15.5 Urenco Limited Recent Developments/Updates
6.16 Rotem Industries, Ltd., Inc.
6.16.1 Rotem Industries, Ltd., Inc. Corporation Information
6.16.2 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.16.5 Rotem Industries, Ltd., Inc. Recent Developments/Updates
6.17 Australian Nuclear Association And Technology Organization (ANSTO)
6.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
6.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments/Updates
6.18 Board of Radiation And Isotope Technology (BRIT)
6.18.1 Board of Radiation And Isotope Technology (BRIT) Corporation Information
6.18.2 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Developments/Updates
6.19 Institute of Atomic Energy Polatom Radioisotope Centre
6.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
6.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments/Updates
6.20 Institute of Isotopes Co., Ltd.
6.20.1 Institute of Isotopes Co., Ltd. Corporation Information
6.20.2 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.20.5 Institute of Isotopes Co., Ltd. Recent Developments/Updates
6.21 Institute Of Radioelement (IRE)
6.21.1 Institute Of Radioelement (IRE) Corporation Information
6.21.2 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Description and Business Overview
6.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Portfolio
6.21.5 Institute Of Radioelement (IRE) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiopharmaceuticals in Nuclear Medicine Industry Chain Analysis
7.2 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiopharmaceuticals in Nuclear Medicine Production Mode & Process
7.4 Radiopharmaceuticals in Nuclear Medicine Sales and Marketing
7.4.1 Radiopharmaceuticals in Nuclear Medicine Sales Channels
7.4.2 Radiopharmaceuticals in Nuclear Medicine Distributors
7.5 Radiopharmaceuticals in Nuclear Medicine Customers
8 Radiopharmaceuticals in Nuclear Medicine Market Dynamics
8.1 Radiopharmaceuticals in Nuclear Medicine Industry Trends
8.2 Radiopharmaceuticals in Nuclear Medicine Market Drivers
8.3 Radiopharmaceuticals in Nuclear Medicine Market Challenges
8.4 Radiopharmaceuticals in Nuclear Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Radiopharmaceuticals in Nuclear Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Radiopharmaceuticals in Nuclear Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) of Key Manufacturers (2018-2024)
Table 5. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/MT) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Radiopharmaceuticals in Nuclear Medicine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2018-2024) & (K MT)
Table 18. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2018-2024)
Table 19. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2024-2029) & (K MT)
Table 20. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2024-2029)
Table 21. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2018-2024)
Table 23. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2024-2029)
Table 25. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2024) & (K MT)
Table 27. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2024-2029) & (K MT)
Table 28. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2024) & (K MT)
Table 32. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2024-2029) & (K MT)
Table 33. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2018-2024) & (K MT)
Table 37. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2024) & (K MT)
Table 42. Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2024) & (K MT)
Table 47. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Type (2018-2024)
Table 51. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Type (2024-2029)
Table 52. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2018-2024)
Table 53. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2024-2029)
Table 54. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2018-2024)
Table 57. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2024-2029)
Table 58. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Type (2018-2024)
Table 59. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Type (2024-2029)
Table 60. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Application (2018-2024)
Table 61. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Application (2024-2029)
Table 62. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2018-2024)
Table 63. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2024-2029)
Table 64. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2018-2024)
Table 67. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2024-2029)
Table 68. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Application (2018-2024)
Table 69. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Application (2024-2029)
Table 70. Bracco Imaging S.P.A. Corporation Information
Table 71. Bracco Imaging S.P.A. Description and Business Overview
Table 72. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 73. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product
Table 74. Bracco Imaging S.P.A. Recent Developments/Updates
Table 75. Cambridge Isotope Laboratories, Inc. Corporation Information
Table 76. Cambridge Isotope Laboratories, Inc. Description and Business Overview
Table 77. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 78. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 79. Cambridge Isotope Laboratories, Inc. Recent Developments/Updates
Table 80. Cardinal Health, Inc. Corporation Information
Table 81. Cardinal Health, Inc. Description and Business Overview
Table 82. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 83. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 84. Cardinal Health, Inc. Recent Developments/Updates
Table 85. Covidien, Plc Corporation Information
Table 86. Covidien, Plc Description and Business Overview
Table 87. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 88. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product
Table 89. Covidien, Plc Recent Developments/Updates
Table 90. Eczacibasi-Monrol Corporation Information
Table 91. Eczacibasi-Monrol Description and Business Overview
Table 92. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 93. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product
Table 94. Eczacibasi-Monrol Recent Developments/Updates
Table 95. Fujifilm Holdings Corporation Corporation Information
Table 96. Fujifilm Holdings Corporation Description and Business Overview
Table 97. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 98. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product
Table 99. Fujifilm Holdings Corporation Recent Developments/Updates
Table 100. GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
Table 101. GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
Table 102. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 103. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product
Table 104. GE Healthcare (Subsidiary Of General Electric Company) Recent Developments/Updates
Table 105. IBA Group Corporation Information
Table 106. IBA Group Description and Business Overview
Table 107. IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 108. IBA Group Radiopharmaceuticals in Nuclear Medicine Product
Table 109. IBA Group Recent Developments/Updates
Table 110. Isotec, Inc. (Sigma-Aldrich) Corporation Information
Table 111. Isotec, Inc. (Sigma-Aldrich) Description and Business Overview
Table 112. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product
Table 114. Isotec, Inc. (Sigma-Aldrich) Recent Developments/Updates
Table 115. Lantheus Medical Imaging, Inc. Corporation Information
Table 116. Lantheus Medical Imaging, Inc. Description and Business Overview
Table 117. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 118. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 119. Lantheus Medical Imaging, Inc. Recent Developments/Updates
Table 120. Nordion, Inc. Corporation Information
Table 121. Nordion, Inc. Description and Business Overview
Table 122. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 123. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 124. Nordion, Inc. Recent Developments/Updates
Table 125. Ntp Radioisotopes (Pty), Ltd. Corporation Information
Table 126. Ntp Radioisotopes (Pty), Ltd. Description and Business Overview
Table 127. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 128. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product
Table 129. Ntp Radioisotopes (Pty), Ltd. Recent Developments/Updates
Table 130. Siemens Healthcare (Subsidiary Of Siemens AG) Corporation Information
Table 131. Siemens Healthcare (Subsidiary Of Siemens AG) Description and Business Overview
Table 132. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 133. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product
Table 134. Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments/Updates
Table 135. Taiyo Nippon Sanso Corporation Corporation Information
Table 136. Taiyo Nippon Sanso Corporation Description and Business Overview
Table 137. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 138. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product
Table 139. Taiyo Nippon Sanso Corporation Recent Developments/Updates
Table 140. Urenco Limited Corporation Information
Table 141. Urenco Limited Description and Business Overview
Table 142. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 143. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product
Table 144. Urenco Limited Recent Developments/Updates
Table 145. Rotem Industries, Ltd., Inc. Corporation Information
Table 146. Rotem Industries, Ltd., Inc. Description and Business Overview
Table 147. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 148. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product
Table 149. Rotem Industries, Ltd., Inc. Recent Developments/Updates
Table 150. Australian Nuclear Association And Technology Organization (ANSTO) Corporation Information
Table 151. Australian Nuclear Association And Technology Organization (ANSTO) Description and Business Overview
Table 152. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 153. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product
Table 154. Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments/Updates
Table 155. Board of Radiation And Isotope Technology (BRIT) Corporation Information
Table 156. Board of Radiation And Isotope Technology (BRIT) Description and Business Overview
Table 157. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 158. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product
Table 159. Board of Radiation And Isotope Technology (BRIT) Recent Developments/Updates
Table 160. Institute of Atomic Energy Polatom Radioisotope Centre Corporation Information
Table 161. Institute of Atomic Energy Polatom Radioisotope Centre Description and Business Overview
Table 162. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 163. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product
Table 164. Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments/Updates
Table 165. Institute of Isotopes Co., Ltd. Corporation Information
Table 166. Institute of Isotopes Co., Ltd. Description and Business Overview
Table 167. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 168. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product
Table 169. Institute of Isotopes Co., Ltd. Recent Developments/Updates
Table 170. Institute Of Radioelement (IRE) Corporation Information
Table 171. Institute Of Radioelement (IRE) Description and Business Overview
Table 172. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 173. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product
Table 174. Institute Of Radioelement (IRE) Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Radiopharmaceuticals in Nuclear Medicine Distributors List
Table 178. Radiopharmaceuticals in Nuclear Medicine Customers List
Table 179. Radiopharmaceuticals in Nuclear Medicine Market Trends
Table 180. Radiopharmaceuticals in Nuclear Medicine Market Drivers
Table 181. Radiopharmaceuticals in Nuclear Medicine Market Challenges
Table 182. Radiopharmaceuticals in Nuclear Medicine Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Radiopharmaceuticals in Nuclear Medicine
Figure 2. Global Radiopharmaceuticals in Nuclear Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2022 & 2029
Figure 4. Diagnostic Radiopharmaceuticals Product Picture
Figure 5. Therapy Radiopharmaceuticals Product Picture
Figure 6. Enriched Stable Isotopes Product Picture
Figure 7. Global Radiopharmaceuticals in Nuclear Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2022 & 2029
Figure 9. Diagnostic Application
Figure 10. Therapeutic Application
Figure 11. Research
Figure 12. Pharmaceutical
Figure 13. Other
Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Market Size (2018-2029) & (US$ Million)
Figure 16. Global Radiopharmaceuticals in Nuclear Medicine Sales (2018-2029) & (K MT)
Figure 17. Global Radiopharmaceuticals in Nuclear Medicine Average Price (USD/MT) & (2018-2029)
Figure 18. Radiopharmaceuticals in Nuclear Medicine Report Years Considered
Figure 19. Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers in 2022
Figure 20. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Radiopharmaceuticals in Nuclear Medicine Players: Market Share by Revenue in 2022
Figure 22. Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2018-2029)
Figure 25. North America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2018-2029)
Figure 29. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2018-2029)
Figure 30. Germany Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2018-2029)
Figure 37. China Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Taiwan Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Philippines Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2018-2029)
Figure 48. Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country (2018-2029)
Figure 53. Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Country (2018-2029)
Figure 54. Turkey Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. U.A.E Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Global Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2018-2029)
Figure 58. Global Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2018-2029)
Figure 59. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Type (2018-2029)
Figure 60. Global Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Application (2018-2029)
Figure 61. Global Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Application (2018-2029)
Figure 62. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/MT) by Application (2018-2029)
Figure 63. Radiopharmaceuticals in Nuclear Medicine Value Chain
Figure 64. Radiopharmaceuticals in Nuclear Medicine Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed